_edited.png)
miRoncol
A miracle in oncology made possible with miRNA
High Performance
Blood-based miRNA Diagnostic Model for Multi-cancer Detection
An innovation enabled with deep expertise in bioinformatics on cancer research
The first-ever miRNA-based multi-cancer detection model
miRNA is widely recognized as a promising biomarker for disease diagnostics. miRoncol developed the first miRNA-based multi-cancer detection model.
​
Unmatched accuracy from the industry
​
At 99.9% specificity, sensitivity showed consistently high across 12 cancers with x range from xxx - to xxx.
​
​
12 types of cancer that have a significant impact if detected earlier
​
Lung cancer
xx
xx
Cancer
​
Initial validation on a large dataset
Our invention has been validated on a large public dataset with over 7000 blood samples providing a strong statistical significance.
miRNA or microRNA - Nobel-wining
​
miRNA as diagnostics biomarker for cancer
Related to Gene expression
​
miRNA is stable and can be handled by existing facilities. No special or expensive equipment required
MCED is proven market - NIH, Grail
​
From extraction, to analysis, to xxx, end of end handling can levarage existing infrastructure.
Based on circulating miRNA, it only requires a blood draw. Therefore, it is non-invasive.
​
miRNA extraction and test can be done at any lab with an RT-PCR machine which is widely available.
